JP2025504936A5 - - Google Patents

Info

Publication number
JP2025504936A5
JP2025504936A5 JP2024544723A JP2024544723A JP2025504936A5 JP 2025504936 A5 JP2025504936 A5 JP 2025504936A5 JP 2024544723 A JP2024544723 A JP 2024544723A JP 2024544723 A JP2024544723 A JP 2024544723A JP 2025504936 A5 JP2025504936 A5 JP 2025504936A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
domain
linker amino
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024544723A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/011727 external-priority patent/WO2023147042A2/en
Publication of JP2025504936A publication Critical patent/JP2025504936A/ja
Publication of JP2025504936A5 publication Critical patent/JP2025504936A5/ja
Pending legal-status Critical Current

Links

JP2024544723A 2022-01-28 2023-01-27 Cns障害を治療するための組成物、デバイス、及び方法 Pending JP2025504936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263304377P 2022-01-28 2022-01-28
US63/304,377 2022-01-28
PCT/US2023/011727 WO2023147042A2 (en) 2022-01-28 2023-01-27 Compositions, devices and methods for treating cns disorders

Publications (2)

Publication Number Publication Date
JP2025504936A JP2025504936A (ja) 2025-02-19
JP2025504936A5 true JP2025504936A5 (enExample) 2026-02-03

Family

ID=87472582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024544723A Pending JP2025504936A (ja) 2022-01-28 2023-01-27 Cns障害を治療するための組成物、デバイス、及び方法

Country Status (6)

Country Link
US (1) US20250144174A1 (enExample)
EP (1) EP4469490A4 (enExample)
JP (1) JP2025504936A (enExample)
CN (1) CN118984840A (enExample)
CA (1) CA3249375A1 (enExample)
WO (1) WO2023147042A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322519A (en) 2023-02-17 2025-10-01 Ablynx Nv Polypeptides that bind to the neonatal fc receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN01115A (enExample) * 2012-07-13 2015-06-26 Zymeworks Inc
TWI833178B (zh) * 2016-12-26 2024-02-21 日商Jcr製藥股份有限公司 通過血腦障壁之新穎抗人類運鐵蛋白受體抗體
EP3784701A4 (en) * 2018-04-24 2022-06-08 National Research Council of Canada THE BLOOD-BRAIN BARRIER TRANSMIGRANT THERAPEUTIC COMPOUNDS AND USES THEREOF
UY38389A (es) * 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
CA3133357A1 (en) * 2019-03-27 2020-10-01 Sigilon Therapeutics, Inc. Compositions, devices and methods for factor vii therapy

Similar Documents

Publication Publication Date Title
JP5667171B2 (ja) 二機能性ポリペプチド
JP2025090743A5 (enExample)
JP2014510518A5 (enExample)
JP2020502051A5 (enExample)
JP2019112445A5 (enExample)
JP2015212284A5 (enExample)
JP2022064924A5 (enExample)
JP2016000731A5 (enExample)
JP2019535321A5 (enExample)
JP2014040483A5 (enExample)
JP2008514618A5 (enExample)
JP2002536960A5 (enExample)
JP2010539921A5 (enExample)
JP2023512454A5 (enExample)
JP2009509535A5 (enExample)
JP2023528204A5 (enExample)
WO2003046560B1 (en) Self-assembly molecules
NO20063026L (no) Antistoffer
JPS60226821A (ja) 化学修飾リンホカインおよびその製造法
JP2008500373A5 (enExample)
JP2010504336A5 (enExample)
JP2015512247A5 (enExample)
JP2016535741A5 (enExample)
JP2003517300A5 (enExample)
JPWO2023234416A5 (enExample)